within Pharmacolibrary.Drugs.C_CardiovascularSystem.C07A_BetaBlockingAgents.C07AB07_Bisoprolol;

model Bisoprolol
  extends Pharmacolibrary.Pharmacokinetic.Models.PK_2C_enteral(
    weight = 70,
    F = 0.88,
    Cl = 4.166666666666667e-06,
    adminDuration = 600,
    adminMass = 10 / 1000000,
    adminCount = 1,
    Vd = 0.13,
    Cmin = 0.001,
    Cmax = 0.01,
    Ctox_peak = 0.02,
    Ctox_trough = 0.01,
    ka = 0.016666666666666666,
    Tlag = 600,
    Vdp = 0.21,
    k12 = 4.444444444444444e-06,
    k21 = 4.444444444444444e-06);

  annotation (Documentation(
    info       = "<html><body><table><tr><td>name:</td><td>Bisoprolol</td></tr><tr><td>ATC code:</td><td>C07AB07</td></tr><td>route:</td><td>oral</td></tr>
    <tr><td>compartments:</td><td>2</td></tr>
    <tr><td>dosage:</td><td>10</td><td>mg</td></tr>
    <tr><td>volume of distribution:</td><td>130</td><td>L</td></tr>
    <tr><td>clearance:</td><td>15</td><td>L/h</td></tr>
    <tr><td colspan='3'>other parameters in model implementation</td></tr>
    </table><p>Bisoprolol is a cardioselective beta-1 adrenergic receptor blocker used for the treatment of arterial hypertension, chronic stable angina pectoris, and chronic heart failure. It is widely approved and used today for cardiovascular indications.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult volunteers after a single oral dose.</p><h4>References</h4><ol><li><p>Nikolic, VN, et al., &amp; Milovanovic, JR (2018). Population Pharmacokinetic Analysis of Bisoprolol in Patients with Stable Coronary Artery Disease. <i>European journal of drug metabolism and pharmacokinetics</i> 43(1) 35–44. DOI:<a href=\"https://doi.org/10.1007/s13318-017-0414-1\">10.1007/s13318-017-0414-1</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/28577178/\">https://pubmed.ncbi.nlm.nih.gov/28577178</a></p></li><li><p>Grevel, J, et al., &amp; Whiting, B (1989). Population pharmacokinetic analysis of bisoprolol. <i>Clinical pharmacokinetics</i> 17(1) 53–63. DOI:<a href=\"https://doi.org/10.2165/00003088-198917010-00005\">10.2165/00003088-198917010-00005</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/2568209/\">https://pubmed.ncbi.nlm.nih.gov/2568209</a></p></li><li><p>Hayes, PC, et al., &amp; Williams, R (1987). Single oral dose pharmacokinetics of bisoprolol 10 mg in liver disease. <i>European heart journal</i> 8 Suppl M 23–29. DOI:<a href=\"https://doi.org/10.1093/eurheartj/8.suppl_m.23\">10.1093/eurheartj/8.suppl_m.23</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/2897298/\">https://pubmed.ncbi.nlm.nih.gov/2897298</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>10/2026 Pharmacolibrary 26.09: model of Drugs.ATC.C.C07AB07 folded in (Drugs.ATC removed)</li><li>06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
    
end Bisoprolol;
